by Zachary | May 22, 2025 | Emerging Trends, Mental Health and Psychiatry, Women's Health
Miley Nguyen, PharmD & Husna Rahim, PharmD Mental Health in Pregnancy: Advancing Care Through Pharmacogenomics. How can pharmacogenomics (PGx) enhance mental health treatment during pregnancy? Hormonal fluctuations during pregnancy significantly increase the risk...
by Zachary | Apr 25, 2025 | Drug Discovery, Emerging Trends
Zachary S. Brooks, PhD, EMBA & Panashe Nyengera Pharmacogenomics for Smarter Drug Discovery. What if drug development began with the patient already in mind? Pharmacogenomics (PGx) merges genomics with pharmacology to refine drug development by linking genetic...
by Zachary | Apr 16, 2025 | Emerging Trends, Rare disease
Chris Moore, MBA & Jayden Lee, EMBA, BCACP, PharmD Pharmacogenomics in Rare Disease: Challenges and Opportunities. How rare is rare? In the U.S. alone, around 30 million people – roughly 1 in 10 – live with a rare disease (Rare Disease, NIH, 2025). 80% of rare...
by Zachary | Apr 12, 2025 | Emerging Trends, Oncology-cancer
Jennifer Tovar, PharmD & Husna Rahim, PharmD Genomic Warfare: Outsmarting Cancer Care with Pharmacogenomics. How can pharmacogenomics (PGx) maximize efficacy and minimize toxicity of cancer treatment? To outsmart cancer, PGx offers a genomic arsenal that enables...
by Zachary | Apr 12, 2025 | Drug Discovery, Emerging Trends
Ayse Ulgen, PhD, MGM & Zachary Brooks, PhD AI Agents in Pharmacogenomics: New Drugs and Predictive Analytics. How can predictive models powered by artificial intelligence (AI) enhance drug development in pharmacogenomics (PGx) research? AI is a powerful tool...
by Zachary | Mar 26, 2025 | Emerging Trends, Pediatrics-children
Husna Rahim, PharmD & Archana Gurudu Translating Adult-Derived Pharmacogenomic Data to Pediatric Populations. Can pharmacogenomic (PGx) data derived from adult-studied populations translate to pediatric patients? While PGx data from adults serves as a universal...
